Immunovia Publ Ab Stock Number Of Employees
| IMMNOV Stock | SEK 0.33 0.01 2.94% |
Immunovia publ AB fundamentals help investors to digest information that contributes to Immunovia Publ's financial success or failures. It also enables traders to predict the movement of Immunovia Stock. The fundamental analysis module provides a way to measure Immunovia Publ's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Immunovia Publ stock.
Immunovia |
Immunovia publ AB Company Number Of Employees Analysis
Immunovia Publ's Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Current Immunovia Publ Number Of Employees | 64 |
Most of Immunovia Publ's fundamental indicators, such as Number Of Employees, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Immunovia publ AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
| Competition |
Based on the recorded statements, Immunovia publ AB is currently employing 64 people. This is 99.42% lower than that of the Healthcare sector and 99.23% lower than that of the Diagnostics & Research industry. The number of employees for all Sweden stocks is 99.66% higher than that of the company.
Immunovia Number Of Employees Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Immunovia Publ's direct or indirect competition against its Number Of Employees to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Immunovia Publ could also be used in its relative valuation, which is a method of valuing Immunovia Publ by comparing valuation metrics of similar companies.Immunovia Publ is currently under evaluation in number of employees category among its peers.
Immunovia Fundamentals
| Return On Equity | -0.38 | |||
| Return On Asset | -0.26 | |||
| Operating Margin | (201.30) % | |||
| Current Valuation | 536.89 M | |||
| Shares Outstanding | 22.63 M | |||
| Shares Owned By Insiders | 36.15 % | |||
| Shares Owned By Institutions | 4.60 % | |||
| Price To Earning | (57.93) X | |||
| Price To Book | 2.21 X | |||
| Price To Sales | 683.47 X | |||
| Revenue | 844 K | |||
| Gross Profit | 15.81 M | |||
| EBITDA | (135.47 M) | |||
| Net Income | (166.63 M) | |||
| Cash And Equivalents | 359.85 M | |||
| Cash Per Share | 18.42 X | |||
| Total Debt | 27.16 M | |||
| Debt To Equity | 7.80 % | |||
| Current Ratio | 14.26 X | |||
| Book Value Per Share | 13.09 X | |||
| Cash Flow From Operations | (152.65 M) | |||
| Earnings Per Share | (7.80) X | |||
| Target Price | 110.0 | |||
| Number Of Employees | 64 | |||
| Beta | 1.29 | |||
| Market Capitalization | 479.62 M | |||
| Total Asset | 493.81 M | |||
| Z Score | 10.2 | |||
| Net Asset | 493.81 M |
About Immunovia Publ Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Immunovia publ AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Immunovia Publ using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Immunovia publ AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Immunovia Stock
Immunovia Publ financial ratios help investors to determine whether Immunovia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Immunovia with respect to the benefits of owning Immunovia Publ security.